Cellumed Co., Ltd. acquired an additional 46.3% stake in Hwankyung ENG Co., Ltd. from Free Telecom Co., Ltd. for KRW 10 billion.
February 09, 2021
Share
Cellumed Co., Ltd. (KOSDAQ:A049180) acquired an additional 46.3% stake in Hwankyung ENG Co., Ltd. from Free Telecom Co., Ltd. for KRW 10 billion on February 9, 2021. Cellumed Co., Ltd. acquired 0.14 million shares of Hwankyung ENG. Cellumed Co., Ltd. held 51% stake in Hwankyung ENG Co., Ltd. and post completion of the transaction holds 97.3% stake.
Cellumed Co., Ltd. (KOSDAQ:A049180) completed the acquisition of an additional 46.3% stake in Hwankyung ENG Co., Ltd. from Free Telecom Co., Ltd. on February 9, 2021.
CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Companyâs products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.
CELLUMED CO.,LTD. 
